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Recently, bacteriophage particles have started to be applied as a new biomaterial for developing 
sensing platforms. They can be used as both a recognition element or/and as building blocks, 
template/scaffold. In this paper, we studied a bacteriophage selected through phage-display 
technology. The chosen bacteriophage acted as a building block for creating a carbon nanofiber-based 
electrode and as a new receptor/binding element that recognizes C-reactive protein (CRP) – one of 
the markers of inflammatory processes in the human body. The binding efficiency of the selected 
phage towards CRP is two orders of magnitude higher than in the wild type. We demonstrate that the 
phage-based sensor is selective against other proteins. Finally, we show that layer-by-layer methods 
are suitable for deposition of negatively charged phages (wild or CRP-binding) with positively 
charged carbon nanofibers for electrode surface modification. A three-layered electrode was 
successfully used for molecular recognition of CRP, and the molecular interactions were studied 
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Bacteriophages (phages, in short) are viruses of bacteria and are the most common biological entities 
on Earth. They are often used in molecular biology, where they serve as model particles. It was 
bacteriophages which led to the proof that DNA contains genetic information. Currently, they have 
found applications in environmental analysis as an indicator of water contamination, and medicine, 
for example, as an alternative to antibiotics (phage therapy) [1]. Moreover, phages can be engineered 
to express specific peptides, thus enabling researchers to modify their chemical properties 
considerably. Therefore, phages can be used to mimic existing biological molecules - for instance, 
antibodies [2–4]. The "phage-display" technique can be applied to generate such artificial antibodies 
[5]. G. Smith and G. Winter were awarded the Nobel Prize in chemistry in 2018 for developing this 
technique. The phage display is an incredible tool with ample opportunities for applications. Phages 
are non-pathogenic organisms for mammals and intrinsic entities of the human body, e.g., in the gut 
or the skin [6–8]. There are studies that have introduced the biopanning of phage libraries against 
eukaryotic cells [9]. Biopanning can be performed in vivo in mice as a model organism [10,11]. Work 
with phages does not require a high-level biosafety laboratory and is usually conducted in basic 
biosafety level 1 laboratory environments.  
 
A relentless search for new applicable materials to be used in electrochemical sensors and electronic 
devices encourages scientists to turn towards interdisciplinary opportunities. In this aspect, the 
linkage of biology, chemistry, and material sciences is especially interesting. Phages – especially the 
filamentous M13 phage – are increasingly used in electrochemical applications as a template/scaffold 
for developing new materials [12–20] or as sensing elements for recognizing bacterial cells [21,22], 
cancer cells [23] or various disease markers [19,24,25]. 
C-reactive protein (CRP) is an annular pentameric protein found in blood plasma. An increased 
concentration of CRP in the blood (above 10 mg L-1) is one of the markers indicative of a state of 
inflammation in the human body [26]. It is an acute-phase protein, and circulating concentrations rise 
rapidly and extensively in a cytokine-mediated response to tissue injury, infection, and inflammation 
processes. This increase follows secretion of interleukin-6 by macrophages and T cells. CRP is 
synthesized primarily in liver hepatocytes, but also in smooth muscle cells, macrophages, endothelial 
cells, lymphocytes, and adipocytes. It binds to lysophosphatidylcholine expressed on the surface of 
dead or dying cells to activate the complement system via C1q [27]. CRP occurs in two isoforms, 
native and monomeric CRP, termed nCRP and mCRP, respectively. The nCRP and mCRP forms are 




influence the level of proinflammatory cytokine (IL-8, MCP-1), and has prominent anti-inflammatory 
activities [28]. Currently, both of these isoforms are being thoroughly investigated in inflammation 
and infection [28,29]. 
Generally, anti-nCRP antibodies [30] are used for CRP assays (anti-mCRP are not available [28]). 
However, also several so-called artificial antibodies like aptamers, with an assay range 0.005–125 ng 
mL-1 [31], affimers with detection range 0–1000 nM [32], polypeptide-conjugate binders (2–500 mg 
L-1) [33] and molecularly imprinted polymers (10−12–10−1 ng mL−1) [27], have been used for 
molecular recognition of CRP. CRP is essential for monitoring and diagnosing various conditions 
such as cardiovascular, tumours, and autoimmune diseases [26]. Even though the main function of 
CRP is well-known in the literature, there is still a need to investigate its role in the body further. 
Recently, CRP was identified as one of the markers of rheumatoid arthritis [36].  
Serum CRP values are routinely measured to detect and monitor many human diseases. While 
bacterial infection and active inflammation can increase of the CRP level of between 40–200 mg L-1 
a smaller response (10–40 mg L-1) is observed for viral infections and any mild inflammations. In the 
case of serious bacterial infections and burns, the CRP level can increase above 200 mg L-1 [37]. 
Therefore, CRP testing is essential for the differentiation between viral and bacterial infections, which 
is especially important with the advent of antimicrobial resistance [37]. 
According to the American Society of Microbiology, there is a constant need to develop innovative, 
rapid diagnostics that can quickly identify whether patients need antibiotics [38]. Generally, an 
evaluation of the CRP concentration in blood is performed using standard molecular diagnostic tools 
like automated immunotubindimetry or immunonephelometry with a detection range from 50 ng mL-
1 to 10 μg mL-1, and enzyme-linked immunoassay (ELISA) with an assay range to 100 ng mL-1 [39]. 
However, these techniques are expensive, laborious, and require skilled personnel. New CRP 
methods are being developed, which in contrast to the techniques mentioned above, can be cheaper, 
faster, easier to use, and can be miniaturized. These include such methods as chemiluminescence with 
detection range 0.3–3000 ng mL-1 [40], colorimetry (0.889–20.7 μg mL-1) [41] electrochemistry (0–
1000 nM, 5–220 fg mL-1) [32,42], fluorescence (0.01–29 mg L-1) [43], surface plasmon resonance 
(2–5 μg–mL-1) [44], and lateral flow device detection (0.039–2.5 μg mL-1) [45]. Commercially 
available CRP tests, which are based on antibodies, are expensive, which significantly limits their 
accessibility. Therefore, the approach of using phage particles and the phage-display method for the 





In this report, a new sensing element – a CRP-binding bacteriophage, generated via phage-display 
technology - is presented. An application in molecular recognition of CRP is demonstrated. The 
binding efficiency of the selected phage towards CRP is two orders of magnitude higher in 
comparison with the wild type. We also demonstrate the selectivity of the new phage against other 
proteins. We used a layer-by-layer (LbL) method for immobilization of the negatively charged phage 
(wild or CRP-binding) with positively charged carbon nanofibers on the electrode surface via 
electrostatic interactions. So far, only covalent binding was utilized for immobilization of the M13 
phage on a substrate via LbL [46]. Electrochemical characterization of electrodes modified with the 
CRP-selective phage (P2-CRP) and the phage together with carbon nanofibers (P2-CRP/CNF) show 
that these electrodes are recognizing the CRP in the range from 4 to 40 𝜇g mL-1. The electrode 
modified with three layers of P2-CRP/CNF exhibited the best performance in the detection of CRP, 
making it a promising biosensing platform. The new CRP-binding phage obtained within our studies 
could become a long-sought-after superior alternative to traditionally used antibodies and could be 
utilized as artificial antibodies for the differentiation between viral and bacterial infections. 
 
2. Materials and methods 
2.1. Chemicals and Materials 
Potassium hexacyanoferrate(III) (K3[Fe(CN)6]), potassium hexacyanoferrate(II) trihydrate 
(K4[Fe(CN)6] ·3H2O), Tween 20, Trisma base, glycine, and polyethylene glycol (PEG) were 
purchased from Sigma-Aldrich. Sodium perchlorate (NaClO4, Fluka), PBS tablets (phosphate-
buffered saline; 137 mM NaCl, 2.7 mM KCl, and 10 mM phosphate buffer, pH 7.4) in Biotechnology 
Grade, TM buffer (10 mM Tris-HCl + 10 mM MgSO4), ethanol 96%, NaCl, HCl, MgSO4, and MgCl2 
were purchased from Chempur (Poland). Wild-type bacteriophage (M13 KE phage (1.0×1010 plaque-
forming units (pfu) pfu mL-1), phages with a linear 12-mer peptide exposed on the protein III of 
M13KE phage (Ph.D-12 Phage Display Peptide Library), and Escherichia coli ER2738 were 
purchased from New England Biolabs, NEB. BactoAgar and LB were obtained from Roth 
(Germany). 
Proteins: Human C-reactive protein (CRP) was bought from Biorbyt (UK). Myoglobin (Mb) from 
horse heart (90 %), troponin T (TnT) from human cardiac muscle (in the form of lyophilized powder), 
human serum albumin (HAS), interleukin-6 (IL-6), human serum normal, and bovine serum albumin 
(BSA) (lyophilized powder) were purchased from Sigma (USA). Fibrinogen (Fb) from human plasma 




Carbon nanofibers (CNF) - were synthesized and characterized as reported in the literature [47]. 
Invitrogen™ Dynabeads™ M-270 Epoxy surface-modified magnetic nanoparticles (mNP) were 
purchased from Thermo Fischer Scientific (USA). Glassy carbon electrodes (GCE) (d = 2 mm) were 
purchased from Mineral Company. All chemicals were used without further purification. The 
sequencing of pIII gene of phage was performed by Genomed (Poland). 
 
2.2. CRP binding bacteriophage isolation and characterization 
In order to select bacteriophages that bind to CRP, a panning procedure was performed in the 
way described in the Phage Display Manual (NEB) [48] and our previous studies [18]. First, a CRP 
solution (100 µg mL-1) was attached to the surface of magnetic nanoparticles beads (5 mg) (modified 
with epoxy groups, which enable the formation of amide bonds with CRP) to perform the screening 
process three-dimensionally and also to utilize a magnetic field to separate bound and unbound 
phages. The conjugation/incubation of the CRP to Dynabeads™ M-270 was performed with the 
addition of buffers, 3 M ammonium sulfate in 0.1 M sodium phosphate buffer pH 7.4, and 0.1 M 
sodium phosphate buffer pH 7.4, as recommended. After overnight incubation, coated beads were 
washed four times using 0.1% PBST (PBS , 0.1 % Tween-20). Then, 0.1% BSA in PBS solution was 
added to the obtained conjugate (CRP-mNP) in order to eliminate/block unspecific binding sites. 
Next, 10 µL of Phage Display Peptide Library was added to the CRP-mNP solution and incubated 
for one hour at room temperature (RT) with gentle shaking. The time of incubation has been 
optimized and is explained in more detail in our previous study [18]. Unbound phages were separated 
from CRP-mNP using a magnetic rack. The CRP-mNP were washed: six times using 0.1% PBST (in 
the first panning) and ten times with 0.5% PBST (in the next two pannings). Phages that bound CRP 
were eluted with 1 mL of 0.1 M glycine in HCl buffer (pH 2.2) for 10 min. The eluted phage solution 
(E1) was collected (using a magnetic rack) and directly titrated and amplified. Amplification of the 
phage has been performed in Escherichia coli ER2738 (NEB) according to the NEB protocol [48]. 
This procedure was used again in the next panning. After amplification, phages were used for the 
subsequent panning. A total of three rounds of panning were performed following the procedure 
described above. Following the last panning step, the eluted phages E3 were titrated on double-agar 
plates containing IPTG/X-gal. In the end, whole plate titration was performed from the E3 lysate to 
obtain single phage clones. Ten phage-clones were selected and amplified using the same procedure 
as reported above. The DNA strands were isolated from the selected ten phages, purified in the way 




In order to characterize the selected clones, the value of the binding efficiency for CRP binding 
was calculated for each of them. The binding efficiency is presented as O/I − a ratio of the output 
phage number (phages eluted/O) to the input phage number (phages incubated/I with the target 
protein, CRP). The P2-CRP phage were selected for further studies based on a high binding efficiency 
(1.32 × 10-4 for n=3 (RSD 5.6 × 10-5)) and on a high concentration after amplification. As a control, 
wild-type M13 phage was used. The panning procedure was performed for the control phage in the 
same way as described above. The same volume (10 µL) and the same concentration (1.0 × 1010 pfu 
mL-1) of the wild-type M13 lysate was added to a new suspension of CRP-mNP. The value of the 
binding efficiency, which was 1.6 × 10-6, was calculated in the same way. 
The selectivity of the selected P2-CRP phage against other proteins was investigated. For this 
purpose, the panning was performed for these selected proteins (human serum albumin, interleukin-
6, myoglobin, troponin T, and fibrinogen) with the CRP-binding phage (P2-CRP). The same volume 
(10 µL) and the same concentration (1.6 × 1012 pfu mL-1) of the P2-CRP lysate was added to a new 
suspension of either HAS, IL-6, Mb, TnT, Fb-mNP, with the same concentrations, separately. Eluted 
phages from the corresponding protein suspension were titrated, and the binding efficiency assay 
parameters were calculated analogously as it was done for CRP.  
2.3. Surface characterization 
TEM analysis 
Suspensions of CNF (3 mg mL-1), P2-CRP phages (1.6 × 1011 pfu mL-1) and P2-CRP phages with 
CNF (3 mg mL-1) were adsorbed onto carbon-coated copper grids (Sigma) for 3 minutes and stained 
with 1.5% uranyl acetate. The samples were imaged and the images processed with iTEM software. 
X-ray photoelectron spectroscopy (XPS) 
Samples were prepared as follows: 10 µL droplets of the P2-CRP phage (1.6 × 1010 pfu mL-1) 
suspension, 10 µL CNF suspensions (3 mg mL-1), or the same volume of the CNF suspensions with 
P2-CRP were deposited on silicon wafer surfaces. Next, they were left to dry at room temperature. 
All further technical details were consistent with those in our earlier studies [18]. 
2.4. Electrode modification 
A surface of a glassy carbon electrode (GCE) was first polished with alumina powder (diameter = 
0.05 µm), then rinsed with water followed by 20 minutes of sonication first in water and next in 
ethanol. Then alternately 2 µL of the solution of negatively charged bacteriophage (M13 or P2-CRP, 
1.0 × 106 or 1.6 × 106 pfu mL-1) and 2 µL of the positively charged CNF suspension (3 mg/mL of 




or five layers on the GCE labelled as 1,3,5L-M13(P2-CRP)/CNF. In the present study, "one layer" 
denotes a combination of a layer of the phage and CNF. GCE electrodes modified with only CNF or 
only M13/(P2-CRP) deposits were labelled as CNF and M13/(P2-CRP). The illustration for electrode 
modification with M13 or P2-CRP and CNF is presented in Schematic 1. 
 
 
Schematic 1. An illustration of the GCE modification with an M13 wild bacteriophage, CRP binding 
bacteriophage (P2-CRP), CRP binding bacteriophage, and carbon nanofibers M13(P2-CRP)/CNF) 
employing the layer-by-layer method. 
2.5. Apparatus 
A three-electrode cell was used for performing electrochemical experiments, with a glassy carbon 
electrode (GCE) or modified GCE, a platinum wire (d = 0.5 mm), and an Ag|AgCl|KClsat electrode 
employed as the working, counter, and reference electrodes, respectively. Cyclic voltammetry 
measurements were performed using a µAutolabIII (Metrohm Autolab) potentiostat powered by 
GPES 4.9 software. All experiments were performed at ambient temperature (22 ± 3 °C). XPS 
analysis was performed with a Scanning XPS Microprobe instrument - PHI 5000 VersaProbe 
(ULVAC-PHI, Japan/USA); details are described elsewhere [18]. TEM images were obtained and 
analyzed with a transmission electron microscope (Tecnai G2 Spirit BioTWIN). Demineralized and 
ultrapure water, with a specific resistivity of 18.2 MΩ cm, from a water purification system 
(Sartorius), was utilized for experiments. 
 
3. Results and discussion 
The phage-display method was employed to identify bacteriophage, which selectively binds to 
CRP. The technique was based on several subsequent biopanning steps. Selection is made from a 
population containing a large number of variants of phages (a combinatorial phage library) using an 
approach resembling natural selection (directed evolution). We have used a commercial Phage 




three cycles of biopanning, ten clones have been selected and verified based on the analysis of the 
value of the binding efficiency (O/I). The clone named P2-CRP exhibited the highest O/I of the tested 
phages (1.32 × 10-4 for n = 3 (RSD 5.6 × 10-5)). The obtained O/I values are two to four orders of 
magnitude higher than those obtained for other clones (3.57 × 10-6 – 7.50 × 10-8), e.g., P1 (3.57 × 10-
6), P4 (4.0 × 10-7) and P8 (5.0 × 10-8) (Fig. 1). Also, the binding efficiency of this selected phage 
towards CRP is two orders of magnitude higher in comparison to the wild type phage (Fig. 1). The 
sequence analysis of the pIII gene of the P2-CRP phage revealed that the 12-mer peptide is expressed 
at the N-terminus of the protein pIII. The amino acid sequence is presented as follows: 
GGSDPEGMQGNY (pI = 3.29). 
 
Fig. 1. The efficiency of CRP binding by the selected clones of phages: P1, P2, P4, P8 -CRP phage, 
and by the wild type phage M13.  
 
Next, the binding efficiency assay of the P2-CRP phage was performed for myoglobin, fibrinogen, 
human serum albumin, interleukin-6, and troponin T. These proteins have been selected because of 
their presence in the human blood (HSA), participation in inflammatory reactions (IL-6), similar size 
to CRP (Fb), or/and usefulness in examination with other disease markers, like cardiovascular 
markers (Mb, TnT). The highest binding efficiency (O/I) was obtained for CRP, which is 1.88 × 10-




10-7 and 2.25 × 10-8, respectively. The obtained values of the O/I for control/interfering proteins are 
comparable with the value obtained for wild-type phage with CRP and about two to three orders of 
magnitude lower than that obtained for the P2-CRP phage and CRP (Fig. 1). The obtained O/I values 
indicate that the P2-CRP phage binds most strongly with the CRP. Thus, P2-CRP has been used as a 
recognition element for creating new sensing platforms in our further studies. Phages selected via 
phage display technology have already been used for recognition of various disease markers 
[24,25,50]. However, currently, there are no reports on CRP-binding phages used as a sensor 
recognition element. 
 
In order to prepare a biosensing platform based on the new CRP-binding phage, the layer-by-layer 
method was applied for immobilization of the phage together with carbon nanofibers (CNFs). The 
presence of the CNFs improves the electrical conductivity of the material, and it increases the surface 
area and the number of binding sites for CRP. The electrostatic interactions between the negatively 
charged phages (wild or CRP-binding) and positively charged carbon nanofibers enabled film 
formation on the electrode surface. These interactions have been utilized previously for the 
preparation of wild-type M13/CNF based electrode [17]. However, in this case, the LbL approach is 
utilized for electrode modification, while in the previous studies drop-casting was applied [17]. 
Electrostatic wild-type M13 phage interactions and aggregation into membranes were recently 
reported [51]. 
 
First, the selected CRP-binding bacteriophage, on its own, and with CNF conjugated, were 
investigated and characterized by transmission electron microscopy (TEM). Images in Fig. 2A, 3A 
show fibers of the P2-CRP phage with a length of ca. 1 µm, which is similar to the length of wild 
type M13 (Fig. 2B) and consistent with the literature data [52]. Also, some aggregates of the P2-CRP 
phage fibers are visible. The aggregation effect is well-known in the literature. Filamentous 
bacteriophage fibers tend to interact with each other forming self-assembled/organized aggregates 
and structures [18,53]. However, the aggregates of the P2-CRP fibers differ from the aggregates of 
the wild-type M13. From TEM images can be seen that the P2-CRP fibers (Fig. 2A) have a greater 
tendency to self-assemble compared to the more separated M13 fibers (Fig. 2B). The effect might 
result from the presence of the 12-mer peptide exposed on the surface of the P2-CRP. The sequence 
of the modified peptide has among neutral amino acids also aspartic and glutamic acids, which are 
negatively charged, thus increasing the total negative surface charge of the P2-CRP phage. This extra 




CRP fibers. Furthermore, tyrosine and methionine are present, which might lead to additional − 
stacking and van der Waals interactions between P2-CRP fibers.  
 
 
Fig. 2. TEM images of (A) P2-CRP phage (B) wild-type M13 and (C) carbon nanofibers (CNF). Scale 
bar: 200 nm. 
 
The CNFs alone form unordered, tangled structures (Fig. 2C), which differ from the structures in the 
presence of the P2-CRP phage. Images in Fig. 3B show interactions of P2-CRP phage with CNFs. 
P2-CRP fibers in the presence of the CNFs line up, intersecting each other, and form a unique carpet-
like structure (Fig. 3B (i, ii)). Based on TEM images, it can be seen that P2-CRP phages are 
specifically attached to CNF via their endings and their edges. P2-CRP and CNF fibers aggregate into 
organized 3D layered structures of the size of a few hundred nanometres (Fig. 3B (ii)). Such an 
alignment of M13 phage with CNFs has not been observed. M13 phages bind to CNFs non-




phage-display has been reported to bind specifically CNF only via endings [18]. As can be seen, the 
presence of the peptide on the P2-CRP surface affects not only interactions between the P2-CRP 
phage fibers but also between those fibers and CNF. 
 
 
Fig. 3 TEM images of selected phage (A) P2-CRP and (B) P2-CRP phage with CNF (P2-CRP/CNF). 
Scale bar: (i) 50 nm and (ii) 100 nm. 
 
XPS surface analysis was performed to gather more information about the new material P2-
CRP/CNF. The XPS spectra were collected for all samples: CNF, P2-CRP phage, and conjugate P2-
CRP/CNF. In the case of CNF alone, only two peaks from carbon C1s and oxygen O1s were recorded 
(Table 1, see Supplementary Fig. F1). The obtained results are in agreement with the literature [54]. 




P2-CRP only, indicating similar elemental surface composition (see Supplementary Fig. F2). A 
difference in the relative atomic percentage of aliphatic carbons between the P2-CRP/CNF (34.37 %) 
and P2-CRP (13.80 %) is observed (see Table 1). The results indicate that some amine groups of P2-
CRP phage could interact with CNF carboxylic acid groups, probably via electrostatic interactions. 
The peak at 286.4 eV, which could be attributed to -C-OH, recorded for P2-CRP (see Supplementary 
Fig. F2 A (i)) is up-shifted in comparison to P2-CRP/CNF (see Supplementary Fig. F2 B (i)). In the 
case of the O1s XPS spectra, both analyzed samples (P2-CRP and P2-CRP/CNF) reveal two peaks 
for O=C–OH (carboxyl, 531.1, 531.2 eV) and for O (carbonyl, 533.0, 532.5 eV) groups, which differ 
significantly in their intensity (Fig. Supplementary Fig. F2 (ii), Table 1). An up-shifting and decrease 
in the carboxyl peak intensity for P2-CRP in comparison to P2-CRP/CNF are observed 
(Supplementary Fig. F2 A, B (ii)). The peak at around 535 eV can be attributed to some physisorbed 
water [55]. The XPS N1s spectra recorded for P2-CRP/CNF reveal significant dissimilarities in the 
content of the nitrogen and the number of N1s peaks compared to P2-CRP (Table 1). Beyond the 
peaks at 399.7 400, 400.9 eV, which are attributed to -NH2 and amine plane –NH- groups, an 
additional peak at 402.2 eV assigned to protonated amino groups (-NH3
+) are observed for P2-
CRP/CNF (Table 1). This peak has not been present in the XPS spectra recorded for wild-type M13 
with CNF [17]. The content of the nitrogen for P2-CRP/CNF is almost four times higher than for P2-
CRP (Table 1). This result may indicate that more amide bonds have been formed between the P2-
CRP phage and CNF through high phage loading on the CNF surface. The result also confirms that 
mainly non-covalent binding via electrostatic interactions is responsible for binding the P2-CRP to 
CNFs. The same was also observed previously for the CNF based materials with wild-type M13 or 





Table 1 XPS analysis of P2-CRP bacteriophage, P2-CRP/CNF, and CNF suspension (surface 
composition expressed as an atomic percentage). 
chemical state concentration / at.% 
P2-CRP P2-CRP/CNF CNF 
C1s – 284.6, 284.8 eV (C-Carom, CH) 
C1s – 285.6 eV (C-C, CH2 groups) 
C1s – 286.0, 286.4 eV (C-OH, C-NH2) 
C1s – 286.5 eV (C-OH) 
C1s – 287.8, 287.5, 288.1 eV (C=O) ketone 
C1s – 288.8, 288.9 eV (O=C−N; O=C−C) carboxylate 
C1 – 290.9 eV () 




O1s – 531.1, 531.2 eV (C-OH) 
O1s –532.5, 533.0 eV (C=O) 




N1s – 398.2 eV (pyridinic nitrogen) 
N1s –399.7  400 eV (C-N, C-NH2, C-O) 
N1s – 400.9 eV (N-H, -NH3+) 









































































Cyclic voltammetry was utilized to characterize the electrochemical behaviour of the new P2-
CRP/CNF material. First, electrodes modified with P2-CRP and wild-type M13 phages were 
analyzed. For this purpose, lysates of phages (with the same concentrations), wild-type M13 phage 
(1.0 × 106 pfu mL-1), and selected P2-CRP phage (1.6 × 106 pfu mL-1) were separately deposited on 
GCE electrode surfaces. The selected concentration of the phage lysate (1.6 × 106 pfu mL-1) was 
chosen based on experiments with different phage concentrations (1.6 × 108, 1.6 × 1010, 1.6 × 1014 
pfu mL-1). It was observed that the phage concentration does not significantly affect the 
electrochemical response of the phage-modified electrode (data not shown). The experiments with 
GCE modified with P2-CRP or M13 were performed with an outer-sphere electron transfer redox 
probe, Fe(CN)6
3-/4-. As one can see from the cyclic voltammograms, the values of the peak current 
for the M13 (Fig. 4b) and P2-CRP (Fig. 4c) electrodes are smaller than those observed with the bare 
GCE (Fig. 4a). The smaller currents indicate partial blocking of the electrode surface by the 
hydrophobic phage layer and/or weak wetting with the aqueous electrolyte. The peak-to-peak 
separation for the GCE modified with phages (M13 or P2-CRP) is larger than that for the bare GCE 
The considerable broadening in the current peak widths for the P2-CRP phage (Fig. 4c) reflects a 
slow electron transfer reaction could be linked to P2-CRP being more hydrophobic compared to M13. 




charged P2-CRP and Fe(CN) −36  anions are likely to cause the change in shape observed in 
voltammograms. The pI of the M13 equals 4.2, so in PBS, it is negatively charged. On the surface of 
the P2-CRP phage, the 12-mer peptide is exposed with a pI of 3.9 (the pI was calculated using 
commercial software http://isoelectric.org/). Due to the presence of aspartic and glutamic acids, which 
are negatively charged amino acids, the total surface charge of the phage is extra negative when 
compared to M13. This extra charge can cause stronger repulsion between P2-CRP and Fe(CN) −36 . 
The sequence of the exposed peptide also contains tyrosine and methionine, which might be 
responsible for additional interactions via − stacking and via van der Waals interactions to CNFs. 
We assume that these specific interactions result in different electrochemical behaviour of the 
electrode modified with the P2-CRP compared to the electrode modified with M13 phage. This result 
is consistent with TEM analysis (see Fig. 2). 
 
Fig. 4 Cyclic voltammograms (2nd potential cycle) of (a) a bare GCE electrode or coated with (b) 
wild-type M13 bacteriophage (c) and P2-CRP-binding bacteriophage immersed in 1 mM 
K3[Fe(CN)6] solution in PBS (137 mM NaCl, 2.7 mM KCl, and 10 mM phosphate buffer, pH 7.4). 
Scan rate 10 mV s-1. 
 
Next, in order to simultaneously improve the electrical conductivity of the phage modified electrode 
and to increase the number of phages on the electrode surface, CNFs were introduced. A modified 




from Glu2, Asp4, Asp5, Asp12, and Glu20 are located on the major capsid [56], and additional Asp, 
Glu on the exposed peptide in the case of P2-CRP. To achieve a well-defined surface modification, 
the electrostatic interactions between the phages and positively charged CNFs in suspension 
(confirmed by values of zeta potential dissolved in water (ζ = + 21.3 ± 1.31 mV [17]) were utilized. 
This type of surface modification for phage immobilization on the electrode surface has not been 
previously reported. An electrostatic multilayer film, which comprises negatively charged polyanions 
(poly(acrylic acid)) and positively charged polycation (poly(ethyleneimine)), was reported as a 
platform for M13 phage adsorption [57,58]. The LbL approach has been used previously for the 
immobilization of genetically modified M13 phage by Belcher and coworkers with a covalent binding 
strategy for phage attachment [46].  
 
The GCE electrodes modified with 1 and 3 layers (denoted 1L-M13(P2-CRP)/CNF and 3L-M13(P2-
CRP)/CNF) were examined in the presence of the redox probe Fe(CN) −36 . As shown in Fig. 5, the 
values for the capacitive current and the faradaic current recorded for M13/CNF (Fig. 5A) and P2-
CRP/CNF (Fig. 5B) electrodes increased with the number of layers/materials deposited on the 
electrode surface. In the case of the M13/CNF electrode, the highest value of the current was obtained 
for electrodes modified with three layers (Fig. 5A(c)) in comparison with data for 1L-M13/CNF (Fig. 
5A(b)), bare GCE (Fig. 5A(a)), and CNF modified GCE (Fig. 5B(d)). This result is linked to the 
electroactive surface area. The same trend was observed for the P2-CRP/CNF electrodes (Fig. 5B). 
However, a higher value of the peak current was recorded for 1,3L-P2-CRP/CNF (Fig. 5B (c) 
compared to that for 1,3L-M13/CNF (Fig. 5A (c)). These results arise probably from the fact that P2-
CRP phage with extra 12-mer peptide interacts with CNF differently compared to the interaction with 
M13 (Fig. 3), allowing for more CNF attachment to the electrode surface. Thus, these electrodes give 
well-assembled conductive material, which provides a higher peak current compared to the case of 
M13/CNF. Additionally, it can be seen that the cathodic peak potential of the 3L-P2-CRP/CNF 
modified electrode (Fig. 5B(c)) is shifted by 64 mV towards negative potentials in comparison to that 
for the 3L-M13/CNF modified electrode (Fig. 5A(c)) and the peak-to-peak separation is increased. 
Both could be linked to higher background currents causing some Ohmic distortion. No further 
increase of the faradaic current is observed when the electrode is modified with 5L-M13/CNF, 
because the electrochemical reaction occurs only at the outer layer of M13/CNF. The electrode 






Fig. 5. (A) Cyclic voltammograms (2nd potential cycle) of (a) a bare GCE electrode or coated with 
(b) one (c) three layers of M13/CNF immersed in 1 mM K3[Fe(CN)6] solution in PBS. Scan rate 10 
mV s-1. (B) Cyclic voltammograms (2nd scan) of (a) a bare GCE electrode or coated with (b) one (c) 
three layers of P2-CRP/CNF (d) carbon nanofibers immersed in 1 mM K3[Fe(CN)6] solution in PBS. 
Scan rate 10 mV s-1. PBS (137 mM NaCl, 2.7 mM KCl, and 10 mM phosphate buffer, pH 7.4).  
 
In subsequent studies, the ability of the selected P2-CRP phage to detect CRP is investigated. Firstly, 
2 µL of the P2-CRP phage lysate (1.6 × 106 pfu mL-1) was deposited onto the electrode surface by 
drop-casting. After drying, the obtained electrode was examined in a solution containing 2.5 mM 
[Fe(CN)6]
3- and 2.5 mM [Fe(CN)6]
4- in the presence of CRP at different concentrations from 4 to 40 
𝜇g mL-1. After the addition of the CRP to the solution, the anodic peak currents are decreasing (see 
Fig. 6A), with a linear dependence on CRP concentration (Fig. 6A inset). The decrease in peak current 
indicates that the P2-CRP binds the CRP. Owing to bound CRP blocking the electrode surface, 
electron transfer is hindered. Next, the control experiment was performed with an electrode modified 
with M13 phage (1.0 × 106 pfu mL-1). Measurements were performed in the presence of CRP in the 
same range of concentrations (4 to 40 𝜇g mL-1). Fig. 6B (b-d) show that the addition of CRP with 
concentrations from 4 to 20 𝜇g mL-1 causes values of the anodic currents to only change slightly. This 
result shows that M13 does not specifically recognize the CRP protein. A decrease in the current is 
observed only at the highest concentration of CRP (40 𝜇g mL-1) (Fig. 6B (e) inset). This is likely to 
result from non-specific interactions. As the CRP is established as one of the cardiac markers, the 
selectivity of the P2-CRP phage was studied in comparison to related markers. For this purpose, the 
electrode modified with P2-CRP phage was prepared and examined in the presence of another cardiac 




data, it can be seen that the peak current after the addition of the first portion of Mb (4 𝜇g mL-1) is 
even slightly increasing (Fig. 6C (b)) in comparison with bare GCE (Fig. 6C (GCE)). This current 
increase might indicate that the Mb due to its smaller size (17.8 kDa) in comparison to pentameric 
CRP (120 kDa) can more easily penetrate the hydrophobic layer of the P2-CRP. The interactions 
could make the P2-CRP layer more hydrophilic, thereby improving electron transfer. After the 
addition of further portions of Mb (20 𝜇g mL-1), the anodic peak current is almost unchanged (Fig. 
6C (c,d)). The decrease of the current is clearly visible only at the highest concentration of Mb (40 
𝜇g mL-1) (Fig. 6C (e), inset). This outcome results from non-specific interactions between proteins 
(P2-CRP phage and Mb), similarly to the case observed for the electrochemical behaviour of the 
GCE-M13 in the presence of CRP. From these experiments and data analysis, it can be concluded 
that the P2-CRP phage-modified electrodes recognized the CRP in a selective and specific manner. 
The latter observation/conclusion can be supported by the fact that the electrostatic interactions 
between studied proteins (Mb and CRP) and the phage layer are unlikely because Mb (pI=6.8-7.4 
[59]) and CRP (pI =5.3 and 7.4) are electrically neutral in solutions at pH 7.4. For binding of CRP by 




Fig. 6. (A) Cyclic voltammograms (2nd scan) of GCE electrode and coated with P2-CRP phage 
immersed in 2.5 mM [Fe(CN)6]
3-
 and 2.5 mM [Fe(CN)6]
4-
 in 0.1 M KCl aq containing (a) 0 (b) 4.0 
(c) 10.0 (d) 20.0 and (e) 40.0 𝜇g mL-1 of CRP. Scan rate 10 mV s-1. Inset: The plot of peak current vs 
CCRP concentration. (B) Cyclic voltammograms (2
nd scan) of GCE electrode and coated with M13 
phage immersed in 2.5 mM [Fe(CN)6]
3-
 and 2.5 mM [Fe(CN)6]
4-
 in 0.1 M KCl aq containing (a) 0 (b) 
4.0 (c) 10.0 (d) 20.0 and (e) 40.0 𝜇g mL-1 of CRP. Scan rate 10 mV s-1. Inset: The plot of peak current 
vs CCRP concentration. (C) Cyclic voltammograms (2
nd scan) of GCE electrode coated with P2-CRP 
phage immersed in 2.5 mM [Fe(CN)6]
3-
 and 2.5 mM [Fe(CN)6]
4-
 in 0.1 M KCl aq containing (a) 0 (b) 




vs CMb concentration. The presented results are average values from four experiments, with RSD 
represented by error bars. 
 
In order to improve electrical conductivity and to increase the number of binding sites for CRP on 
the P2-CRP phage modified electrode, CNFs were introduced. As described above, the LbL approach 
was utilized, which enables the immobilization of the P2-CRP phage within the CNFs. The electrodes 
modified with 1 and 3L P2-CRP/CNF were prepared and used for CRP recognition. The current is 
decreasing for both of these electrodes (modified with one (see Supplementary Fig. F3) and three 
layers (Fig. 7)) when the CRP concentration increased from 4 to 40 𝜇g mL-1, which is consistent with 
observations for P2-CRP-modified electrodes (Fig. 6A). The highest value of the anodic peak current 
was recorded for 3L-P2-CRP/CNF (Fig. 7). The lowest value was obtained for P2-CRP modified 
electrodes (Fig. 6A). In the case of the 3L-P2-CRP/CNF electrode, after addition of the first part of 
CRP solution (0.04 𝜇g mL-1), the most visible drop in the peak current was recorded (Fig. 7). We 
hypothesize that at the 3L-P2-CRP/CNF electrode, the P2-CRP phage binds strongly to CNFs, thus 
forming effective percolation paths and that allow for appropriate electron transport. A high phage 
loading gives more binding sites for CRP. The latter effect was also confirmed by XPS analysis (see 
Table 1). Therefore, the electrode modified with 3L-P2-CRP/CNF was selected for further 
characterization in terms of CRP recognition. As depicted in the inset of Fig. 7, the peak current is 
decreasing with increasing concentration of CRP. The obtained calibration curve for CRP exhibits a 
wide linear range of 0.04 – 100 𝜇g mL-1. The regression equation is I = -0.1773c + 19.2967 (c is the 
CRP concentration) with a detection limit (LOD) (S/N = 3) of 0.04 𝜇g mL-1. The reproducibility of 
the 3L-P2-CRP/CNF electrode was calculated based on measurements performed for four electrodes 
for the same concentration of CRP (10 𝜇g mL-1) under the same conditions; the RSD was 9.85 %, 
n=3. The 3L-P2-CRP/CNF electrode maintains 80.71 % of its activity towards 10 𝜇g mL-1 CRP 
recognition after 7 days of storage at 23 ⁰C; the RSD was 11.76 %, n=3. These results indicate good 
stability of the proposed CRP binding phage/CNF electrode. There is no requirement to keep sensor 
electrodes in a fridge like it is customary with most of the antibody-based sensing systems. Moreover, 
the sensing properties of the new CRP binding phage are comparable with other CRP recognition 
elements based electrode [31–33], making it possible to apply such phage as artificial antibodies in 






Fig. 7. Cyclic voltammograms (2nd scan) of GCE electrode coated with 3L-P2-CRP/CNF immersed 
in 2.5 mM [Fe(CN)6]
3- and 2.5 mM [Fe(CN)6]
4- in 0.1 M KCl aq containing (a) 0 (b) 4.0 (c) 10.0 (d) 
20.0 (e) 40 and (f) 100 𝜇g mL-1 of CRP. Scan rate 10 mV s-1. Inset: plot of peak current vs CCRP 
concentration. Results are average values from four experiments, with RSD represented by error bars. 
The selectivity of the 3L-P2-CRP/CNF electrode has been tested in the same way as for the P2-
CRP/M13 electrodes in the presence of Mb/CRP (see Supplementary Figure F4.). The 3L-P2-
CRP/CNF electrode was examined in 2.5 mM [Fe(CN)6]
3-
 and 2.5 mM [Fe(CN)6]
4-
 solution in the 
presence of CRP at different concentrations from 4 to 40 𝜇g mL-1. After the addition of the CRP to 
the solution, the anodic peak currents are decreasing (see Supplementary Figure F4 ▲, Fig. 7). The 
drop of the current indicates that P2-CRP binds to CRP. Next, the control experiment was performed 
with an electrode modified with M13 phage (1.0 × 106 pfu mL-1) (3L-M13/CNF). Measurements were 
performed in the presence of CRP at the same range of concentrations (4 to 40 𝜇g mL-1). As is 
presented in Supplementary Figure F4 (■), when the CRP at concentrations from 4 to 20 𝜇g mL-1 is 
added to the solution, values of the anodic current are only slightly changing. The change is observed 
at the level of 20 % with respect to the initially added concentration of CRP. However, in the case of 
3L-P2-CRP/CNF electrodes changes were higher with ca. 50 %. The smaller change shows that M13 




concentration of CRP (40 𝜇g mL-1) (see Supplementary Figure F4 (■)). But this probably results from 
non-specific interactions between proteins. The 3L-P2-CRP/CNF electrode was prepared and 
examined in the presence of myoglobin (Mb) at the same concentration range (4 to 40 𝜇g mL-1). It 
can be seen that the peak currents after the addition of Mb are almost constant (Supplementary Figure 
F4 (●)). These results are consistent with data for P2-CRP/M13 electrodes (Fig. 6). 
The selectivity of the GCE electrodes modified with P2-CRP phage and 3L-P2-CRP/CNF were tested 
in the presence of a proinflammatory cytokine – interleukin 6 under the same conditions. The results 
are presented in Fig. 8. When the electrodes were incubated with 2.5 µg mL-1 IL-6 solution (P2-CRP-
IL-6 and 3L-P2-CRP/CNF-IL-6), the peak currents did not decrease. The responses of the electrode 
with/without the IL-6 were consistent. This result shows that the P2-CRP phage does not bind to 
selected proinflammatory proteins, only to CRP, and confirms a good selectivity of the electrode 
based on P2-CRP phage.  
 
Fig. 8. The plot of peak current plotted against the response of the GCE electrodes modified with P2-
CRP and 3L-P2-CRP/CNF in the absence and presence of the IL-6 (2.5 µg mL-1) P2-CRP-IL-6, 3L-





To check the selectivity of the 3L-P2-CRP/CNF electrode additional experiments have been 
performed in a mixture of interferents/proteins (mixed proteins: TnT (2.5 µg mL-1), Mb (2.5 µg mL-
1), HAS (2.5 µg mL-1), Fb (2.5 µg mL-1), BSA (2.5 µg mL-1)), natural human serum and at a specified 
concentration of CRP (4 µg mL-1). The results are presented in Fig. 9. When the 3L-P2-CRP/CNF 
electrode was measured in the solution of the mixed protein or human serum, the current did not 
change significantly, and it remained comparable to that in blank experiments (Fig. 8). However, the 
addition of 4.0 µg mL-1 CRP solution into the mixed protein or human serum results in a decrease in 
peak current. In the case of the mixed proteins, the drop in the current is more visible. We hypothesize 
that one of the proteins decreases the hydrophobicity of the CNFs, making the 3L-P2-CRP/CNF more 
effective in the mixed protein solution. This does not occur in the case of the blank or the human 
serum. Nevertheless, these studies require further and more in-depth analysis. The outcomes of these 
preliminary experiments show that the 3L-P2-CRP/CNF electrode is sensitive in the presence of CRP 
and can be applied for recognition of this protein in different media. 
 
Fig. 9. The plot of peak current plotted against the response of the GCE electrodes modified with 3L-
P2-CRP/CNF in the absence and presence of the CRP (4.0 µg mL-1) in the mixed protein and in 
human serum. The mixed protein contains TnT (2.5 µg mL-1), Mb (2.5 µg mL-1), HAS (2.5 µg mL-
1), Fb (2.5 µg mL-1), BSA (2.5 µg mL-1). The results are average values from three experiments, with 





The 1L- and 3L-P2-CRP/CNF electrodes operate in the same range (4-40 𝜇g mL-1) as the P2-CRP 
electrode, making them suitable for future application, for example, to differentiate between viral and 
bacterial infections. However, in the future, more analysis and studies will be required to perform and 
understand more thoroughly the interactions between the exposed peptide on the P2-CRP phage and 
the CRP.  
 
4. Conclusions  
In this study, the phage display technology has been utilized for the generation of a new sensing 
element for C-reactive protein (one of the markers of inflammatory processes in the human body) 
recognition. The high binding efficiency of this new element towards CRP has been studied and 
confirmed in contrast to wild-type M13 and other proteins using biological methods. 
 
The selected phage, with a net negative surface charge, has been used in combination with positively 
charged carbon nanofibers for electrode modification via the LbL method. Electron microscopy 
shows that the CRP-binding phage binds to CNF via ends and edges, forming ordered carpet 
structures. XPS analysis reveals that the selected phage interacts with CNF mainly via electrostatic 
interactions / non-covalent bonding. These interactions have been utilized for the CRP-binding phage 
immobilization on the electrode surface in the presence of CNFs. The role of the phage is twofold, as 
building blocks and as sensing elements. The electrostatically LBL assembled phage-CNF electrode 
has been used successfully for CRP recognition. The sensor operating range enables applications, for 
example, in the differentiation between viral and bacterial infections. The stability, reproducibility, 
and selectivity of the electrode modified with CNFs and phage have been demonstrated using 
electrochemical measurements. 
 
The new CRP-binding phage could become an alternative to traditionally used antibodies and can be 
utilized as artificial antibodies for the differentiation between viral and bacterial infections, thereby 
decreasing the antibacterial resistance problem. Additionally, phages in comparison to antibodies are 
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